| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |